Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Sales | 23,585 | 20,317 | 19,479 | 18,716 | 27,648 |
| Gross Profit | 23,585 | 20,317 | 19,479 | 18,716 | 27,648 |
| Operating Expenses | 53,598 | 47,365 | 52,019 | 52,563 | 58,057 |
| Operating Income | -30,013 | -27,048 | -32,540 | -33,847 | -30,409 |
| Other Income | 993 | 750 | 393 | 255 | 258 |
| Pre-tax Income | -29,020 | -26,298 | -32,147 | -33,592 | -30,151 |
| Income Tax | -34 | 50 | -447 | N/A | -36 |
| Net Income Continuous | -28,986 | -26,348 | -31,700 | -33,592 | -30,115 |
| Net Income | $-28,986 | $-26,348 | $-31,700 | $-33,592 | $-30,115 |
| EPS Basic Total Ops | -1.39 | -1.27 | -1.53 | -1.63 | -1.48 |
| EPS Basic Continuous Ops | -1.39 | -1.27 | -1.53 | -1.63 | -1.48 |
| EPS Diluted Total Ops | -1.39 | -1.27 | -1.53 | -1.63 | -1.48 |
| EPS Diluted Continuous Ops | -1.39 | -1.27 | -1.53 | -1.63 | -1.48 |
| EPS Diluted Before Non-Recurring Items | -1.39 | -1.27 | -1.53 | N/A | N/A |
| EBITDA(a) | $-29,841 | $-26,340 | $-31,634 | $-32,643 | $-29,083 |